Adcendo

Copenhagen, Denmark · Founded 2017 · $265.0M raised

Headquarters
Copenhagen
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$265.0M
Last Round
$75.0M Series CApr 2026
Rounds
3

About

Adcendo is a clinical-stage Copenhagen biotech developing antibody-drug conjugates (ADCs) for underserved cancers, spun out in 2017 from the Finsen Laboratory of Rigshospitalet and the University of Copenhagen by Niels Behrendt, Lars Henning Engelholm, Christoffer Nielsen, and biotech entrepreneur Henrik Stage. Lead program ADCE-D01, the first uPARAP-targeted ADC with a topoisomerase-inhibitor payload, holds FDA Fast Track designation for soft tissue sarcoma and is enrolling the ADCElerate1 dose-escalation and expansion study in mesenchymal cancers. The company, led by CEO Michael Pehl, closed an oversubscribed $75 million Series C in April 2026 led by Jeito Capital with new investors Vida Ventures, Bpifrance, and Denmark’s EIFO, funding three clinical ADC programs through upcoming milestones.

Summary

Adcendo is a Biotech company based in Copenhagen, Denmark, founded in 2017. It has raised $265.0M in total across 3 rounds, most recently a $75.0M Series C round in Apr 2026. Investors include Jeito Capital, Novo Holdings A/S and RA Capital Management.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CApr 2026
$75.0M

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adcendo on Indexed.vc
<a href="https://indexed.vc/companies/adcendo"><img src="https://indexed.vc/api/badge/company/adcendo" alt="Adcendo on Indexed.vc" width="260" height="76" /></a>